|Articles|January 15, 2003

BioPharm International

  • BioPharm International-01-01-2003
  • Volume 16
  • Issue 1

Rethinking the Economics of Chromatography: New Technologies and Hidden Costs

by Tim N. Warner and Sam Nuchumson, Pall Life Sciences If the hidden expenses associated with laboratory purchases ? labor, cleaning, buffers, validation, time delays ? are identified, reduced processing costs, higher throughput, and accelerated time-to-market are possible. This comparison between resin and membrane chromatography helps shed light on some hidden costs.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

about 23 years ago

Virus Inactivation in the 1990s and into the 21st Century: Part 4, Culture Media, Biotechnology Products, and Vaccines

about 23 years ago

Biotech World: Canada's Supreme Court says "No" to Harvard Mouse

about 23 years ago

Outsourcing Outlook: Using Virtual Private Networks to Gain Competitive Advantage

about 23 years ago

Inside Washington: Coverage and Consolidation ? Key Issues for Biotech Companies

about 23 years ago

Employing Near-Infrared Spectroscopic Methods of Analysis for Fermentation Monitoring and Control: Part 2, Implementation Strategies

about 23 years ago

Guest Editorial: At the Governance Crossroad

about 23 years ago

Reducing Costs by Facility Design

about 23 years ago

Guidelines for Optimization and Scale-Up in Preparative Chromatography

about 23 years ago

Analytical Advances: Funneling a Flood Tide of Data ? New Software Accelerates Bioinformatic Analyses

about 23 years ago

Survival Strategies: Board Compensation Changing with the Times

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!